IIT Delhi

Kain Capital Welcomes Ashish Gupta as Chief Technology Officer

Retrieved on: 
Thursday, November 9, 2023

NEW YORK, Nov. 9, 2023 /PRNewswire/ -- Kain Capital LLC, a leading private equity firm focused on the technology enablement of healthcare services companies, today announced that Ashish Gupta has joined the firm as Chief Technology Officer. In this newly created role, Mr. Gupta will lead innovation in AI and machine learning, cloud computing and data analytics to streamline practices for tech-focused healthcare portfolio companies.

Key Points: 
  • NEW YORK, Nov. 9, 2023 /PRNewswire/ -- Kain Capital LLC , a leading private equity firm focused on the technology enablement of healthcare services companies, today announced that Ashish Gupta has joined the firm as Chief Technology Officer.
  • Mr. Gupta holds a PhD in Computer Science from Northwestern University and completed his undergraduate work in computer science at IIT Delhi.
  • "We are delighted to welcome Ashish to the Kain team," said Steven Yecies, Managing Partner at Kain Capital.
  • "I'm excited to bring my commitment to facilitating data accessibility to Kain Capital," said Mr. Gupta.

BPGbio Announces Appointments to its Leadership Team to Accelerate Research and Commercialization

Retrieved on: 
Monday, March 6, 2023

Dr. Thakurta’s leadership and scientific contributions have led to six approved cancer drugs in multiple indications.

Key Points: 
  • Dr. Thakurta’s leadership and scientific contributions have led to six approved cancer drugs in multiple indications.
  • Prior to BPGbio, Dr. Thakurta was the Vice President, Translational Medicine at Bristol Myers Squibb where he oversaw the hematological malignancy group.
  • Before BMS, Dr. Thakurta served several leadership roles at Celgene, AstraZeneca and Biogen Idec and the United States National Cancer Institute (NCI) earlier in his career.
  • Prior to BPGbio he led strategy and investments for Innova Medical Group and was a Principal at Pasaca Capital.

Elucidata Raises $16 Million Series A to Reimagine AI Infrastructure for the Life Sciences Industry

Retrieved on: 
Tuesday, September 27, 2022

Elucidata's platform Polly, enables pharmaceutical and diagnostic companies to adopt a data-centric approach for successful AI/ML initiatives.

Key Points: 
  • Elucidata's platform Polly, enables pharmaceutical and diagnostic companies to adopt a data-centric approach for successful AI/ML initiatives.
  • Used by leading life sciences companies on over 2.5 million biomolecular datasets, Polly leverages proprietary Bio-NLP technology to rapidly curate biomedical data with human-levels of accuracy, making it machine learning-ready (ML-ready).
  • Elucidata sees the era of AI as one in which life sciences companies leverage the benefits of AI.
  • In May this year, Eight Roads launched its first dedicated US$250 million healthcare and life sciences fund for India.

Timechain Labs to be the development partner for Elteridium Technologies

Retrieved on: 
Wednesday, September 7, 2022

MUMBAI, India, Sept. 7, 2022 /PRNewswire/ --Mumbai-based BSV Blockchain-focused start-up, Timechain Labs Pvt Ltd (TCL) ( https://www.timechainlabs.io/ ) has announced a strategic partnership with the Bengaluru-based Elteridium Technologies ( https://www.elteridium.com ) that specializes in public-private partnership (PPP) contracts.

Key Points: 
  • MUMBAI, India, Sept. 7, 2022 /PRNewswire/ --Mumbai-based BSV Blockchain-focused start-up, Timechain Labs Pvt Ltd (TCL) ( https://www.timechainlabs.io/ ) has announced a strategic partnership with the Bengaluru-based Elteridium Technologies ( https://www.elteridium.com ) that specializes in public-private partnership (PPP) contracts.
  • The two companies have agreed that TCL would build end-to-end blockchain solutions that derive from tokenization and smart contracts based on the legal and PPP expertise of Elteridium Technologies.
  • TCL, founded by IIT Kharagpur alumnus Sharan, has been leading the efforts to drive the adoption of the BSV Blockchain in India since its founding in October 2021.
  • "Public-private partnerships constitute a $300 billion market in India alone.

Timechain Labs to be the development partner for Elteridium Technologies

Retrieved on: 
Wednesday, September 7, 2022

MUMBAI, India, Sept. 7, 2022 /PRNewswire/ --Mumbai-based BSV Blockchain-focused start-up, Timechain Labs Pvt Ltd (TCL) ( https://www.timechainlabs.io/ ) has announced a strategic partnership with the Bengaluru-based Elteridium Technologies ( https://www.elteridium.com ) that specializes in public-private partnership (PPP) contracts.

Key Points: 
  • MUMBAI, India, Sept. 7, 2022 /PRNewswire/ --Mumbai-based BSV Blockchain-focused start-up, Timechain Labs Pvt Ltd (TCL) ( https://www.timechainlabs.io/ ) has announced a strategic partnership with the Bengaluru-based Elteridium Technologies ( https://www.elteridium.com ) that specializes in public-private partnership (PPP) contracts.
  • The two companies have agreed that TCL would build end-to-end blockchain solutions that derive from tokenization and smart contracts based on the legal and PPP expertise of Elteridium Technologies.
  • TCL, founded by IIT Kharagpur alumnus Sharan, has been leading the efforts to drive the adoption of the BSV Blockchain in India since its founding in October 2021.
  • "Public-private partnerships constitute a $300 billion market in India alone.

Singapore based Healthcare Company Receives Coveted WHO certification for its Vaccine Data Logger

Retrieved on: 
Sunday, May 22, 2022

The WHO PQS certification is a rigorous process of prequalifying products and devices to ensure consistent and world-class quality across its supply chain.

Key Points: 
  • The WHO PQS certification is a rigorous process of prequalifying products and devices to ensure consistent and world-class quality across its supply chain.
  • It is a data logger used in cold chain monitoring during transportation, storage and refrigeration as manufacturers and governments grapple with a complex vaccine distribution system in the wake of the COVID-19 pandemic.
  • We are pleased with Inspired Technology's latest WHO PQS certified data loggers and wish the team the very best.
  • With this certification, Inspired Technology's Vac-TL-01, has become one of the world's few data loggers to achieve this certification and endorsement from the WHO.

Singapore based Healthcare Company Receives Coveted WHO certification for its Vaccine Data Logger

Retrieved on: 
Wednesday, May 18, 2022

The WHO PQS certification is a rigorous process of prequalifying products and devices to ensure consistent and world-class quality across its supply chain.

Key Points: 
  • The WHO PQS certification is a rigorous process of prequalifying products and devices to ensure consistent and world-class quality across its supply chain.
  • It is a data logger used in cold chain monitoring during transportation, storage and refrigeration as manufacturers and governments grapple with a complex vaccine distribution system in the wake of the COVID-19 pandemic.
  • We are pleased with Inspired Technology's latest WHO PQS certified data loggers and wish the team the very best.
  • With this certification, Inspired Technology's Vac-TL-01, has become one of the world's few data loggers to achieve this certification and endorsement from the WHO.

Convin - the platform that reimagines virtual assisted selling for businesses, has raised $2.1M in seed funding from Kalaari Capital

Retrieved on: 
Wednesday, April 27, 2022

BENGALURU, India, April 27, 2022 /PRNewswire/ -- Bengaluru-based startup Convin , which enables businesses to enhance their virtual assisted selling services for their customers, has raised $2.1m in the seed funding round.

Key Points: 
  • BENGALURU, India, April 27, 2022 /PRNewswire/ -- Bengaluru-based startup Convin , which enables businesses to enhance their virtual assisted selling services for their customers, has raised $2.1m in the seed funding round.
  • The investment was led by Kalaari Capital and backed by Good Capital, Plan B Innovations, Bharat Founders Fund, and Digital Sparrow.
  • Convin will utilize the funding to fuel its end-to-end assisted selling platform development and expand the product & GTM teams.
  • Convin believes that they are one step closer to providing an all-in-one platform for assisted selling with this new note of confidence.

Dream Capital Leads $120M Investment in Cricket NFT Platform Rario

Retrieved on: 
Tuesday, April 26, 2022

Rario, creators of the worlds first cricket NFT platform, today announced a $120 Million Series A funding round led by Dream Capital , the Corporate Venture Capital and M&A arm of Dream Sports .

Key Points: 
  • Rario, creators of the worlds first cricket NFT platform, today announced a $120 Million Series A funding round led by Dream Capital , the Corporate Venture Capital and M&A arm of Dream Sports .
  • With Dream Capitals investment, Rario now gets access to Dream Sports 140 Million users, who will be offered FIAT-only products in India, with the potential to create the largest cricket NFT platform globally.
  • This is currently the largest investment by DreamCap, and also the single largest investment in the cricket NFT space globally.
  • Rario is a digital collectible platform for cricket fans to collect and trade officially licensed cricket moments on the blockchain, represented as a non-fungible token (NFT).

Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC

Retrieved on: 
Thursday, April 7, 2022

In addition, CCI has an impressive international team of physician leaders, diplomats, hospital administrators, and regulatory/FDA experts.

Key Points: 
  • In addition, CCI has an impressive international team of physician leaders, diplomats, hospital administrators, and regulatory/FDA experts.
  • I cannot think of a better partnership for CCI and the CCI team and it is my honor to join the Novo team with this acquisition.
  • Novo Integrated Sciences, Inc. is pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation.
  • Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient first platforms.